Pharma Marketing Network

OCTOBER 28, 2023

Patient-centricity is a concept that is gaining traction in the pharmaceutical industry. It is a shift from a traditional focus on drug development and marketing to a focus on the patient’s needs. This shift is being driven by advances in digital communication, which are allowing companies to better understand and meet the needs of their patients. In this article, we will explore the concept of patient-centricity, its impact on digital communication in pharma, the benefits it brings, and the cha

Pharma Companies 52

Pharma Companies Marketing Development Sales 52

Roots Analysis

OCTOBER 28, 2023

On 26 October 2023, Eisai and Biogen’s Alzheimer’s drug, Leqembi, was found to be as effective as the current intravenous administration in removing toxic brain plaques. However, the review conducted by the drugmakers revealed that the rates of serious side effects were higher when using the drug in its subcutaneous injection form. The company’s analysis compared data from 72 early Alzheimer’s patients who received Leqembi through subcutaneous injection to prior pivotal t

Drugs 40

Drugs Drug Delivery Marketing Clinical Trials 40

Drug Patent Watch

OCTOBER 28, 2023

This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Spain. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating… The post Which pharmaceutical companies have the most SPCs in Spain? appeared first on DrugPatentWatch - Make Better Decisions.

59

59